Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Rapport
Geschatte realtime Cboe BZX  -  17:22:58 01-02-2023
43.73 USD   -0.99%
17:07Pfizer, Inc. : BMO Capital herhaalt koopadvies
MM
17:07Pfizer, Inc. : UBS vindt het aandeel niet inspirerend
MM
16:08PFIZER INC : UBS herhaalt het Neutraal advies
MD
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op PFIZER, INC.
15:12First To File : Issue 9
15:05MassBio - Pfizer Pharma Day to ignite breakthrough partnerships
14:52Cronache di Borsa - Mercoledì 1 Febbraio
11:09GSK: bénéfice 2022 dopé par la scission des soins grand public
08:44Morning Briefing - Markt Schweiz
08:27Novartis présente la candidature d'un ancien de Pfizer pour son conseil
07:24Novartis schlägt früheren Pfizer-Manager für den Verwaltungsrat vor
07:13Wall Street : clôture en nette hausse dans l'attente du FOMC
05:59China mRNA vaccine development jumps into high gear
03:54Simcere Starts Marketing Oral COVID-19 Drug at 40% Less Than Price of Pfizer’s Pa..
31/01Factbox-What ending the U.S. COVID health emergency means for your pocket
31/01Health Care Edges Higher After Mixed Pfizer Earnings -- Health Care Roundup
31/01Aktien New York Schluss: Dow und S&P 500 machen Vortagsverluste ..
31/01Ganancias destacadas en un Wall Street que descuenta resultados
31/01MÄRKTE USA/Fester - US-Notenbank und Berichtssaison im Fokus
31/01Aktien New York: Deutliche Erholung vor Fed-Zinsentscheid und nach Zahle..
31/01Bourses: l'Europe prudente, Wall Street positive
31/01Point marchés-L'Europe finit dans le désordre, attentisme sur les banques centrales
31/01Drugmaker Pfizer starts low with 2023 earnings forecast
31/01MÄRKTE USA/Etwas fester - US-Notenbank und Berichtssaison im Fokus
31/01Global markets live: GM, Pfizer, Exxon, UBS, Boeing...
31/01Wall Street : amorce de rebond à la veille de la Fed
31/01CAC40 : finit 1 mois de janvier record sans perdre de terrain
31/01Pfizer prevede forte calo vendite prodotti Covid in 2023
31/01La prudence se confirme sur les marchés boursiers avant les banques centrales
31/01CAC40 : gain de +9,4% en janvier, beaucoup de stats en Europe
31/01Wall Street ouvre en hausse, la hausse des salaires ralentit
31/01Rückenwind durch Corona-Pandemie lässt bei Pfizer nach
31/01MÄRKTE USA/Wall Street zum Start leicht im Plus
31/01Pfizer prevede forte calo vendite prodotti Covid in 2023
31/01Pfizer rechnet 2023 mit schleppendem Corona-Geschäft und weniger Gewinn
31/01Dpa-AFX-Überblick: UNTERNEHMEN vom 31.01.2023 - 15.15 Uhr
31/01Wall Street : les résultats peinent toujours à convaincre
31/01Les valeurs à suivre aujourd'hui à Wall Street - Mardi 31 janvier 2023
31/01Investor optimism is about to be tested
31/01Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
31/01Sector Update: Health Care
31/01Traders Tread Cautiously as Fed Starts Two-Day Meeting, Fueling Narrow Premarket Losses..
31/01Aktien New York Ausblick: Leicht erholt vor Fed-Zinsentscheid
31/01Pfizer : annonce des revenus record mais anticipe des bénéfices 2023 en nette bai..
31/01Pfizer Issues Downbeat Full-Year Outlook With Revenue From COVID-19 Products Set to Tum..
31/01Pfizer: prevede ricavi da vaccini in calo a 13,5 miliardi nel 2023
31/01Pfizer anticipe en 2023 un recul plus important des ventes de ses produits contre le CO..
31/01Pfizer s'attend à une chute des ventes de son vaccin anti-Covid en 2023
31/01Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on December 14, 2018.
31/01Pfizer Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
31/01Pfizer Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
31/01Haleon appoints Pfizer Chief Financial Officer David Denton to board
31/01Les Bourses troublées par des indicateurs macroéconomiques
31/01Pfizer prevé ventas débiles de productos contra el COVID en 2023
31/01Futures drop as earnings roll in, Fed rate decision in focus
31/01Pfizer: nel 2022 record, oltre 100 miliardi di dollari
31/01Pfizer : hausse de 44% du bénéfice net au 4e trimestre
31/01WDH: Pfizer rechnet 2023 mit schleppendem Corona-Geschäft und weniger Gewinn
31/01Pfizer's Q4 Adjusted Earnings, Revenue Rise; Fiscal 2023 Outlook Set
31/01Pfizer : Q4 Earnings Snapshot
31/01GUIDANCE: (PFE) PFIZER Forecasts Fiscal Year 2023 Adjusted EPS Range $3.25 - $3..
31/01Earnings Flash (PFE) PFIZER Posts Q4 Revenue $24.29B, vs. Street Est of $24.40B
31/01Earnings Flash (PFE) PFIZER Posts Q4 Adjusted EPS $1.14, vs. Street Est of $1.04
31/01Futures Continue to Trend Down Pre-Bell Ahead of Fed Policy Meeting; Asia, Europe Fall
31/01With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Break..
31/01Pfizer : Fourth Quarter 2022 Press Release
31/01Pfizer forecasts 2023 sales of COVID products below estimates
31/01Pfizer reports record full-year 2022 results and provides full-year 2023 financial guid..
31/01Pfizer Inc. Provides Earnings Guidance for the Financial Year 2023
31/01North American Morning Briefing: Stocks Seen Down -3-
31/01North American Morning Briefing: Stocks Seen Down as Rat..
31/01European Midday Briefing: Mood Dampens Ahead of Central Banks
31/01USA-Les valeurs à suivre à Wall Street (actualisé)
31/01Tech Earnings, Fed Views Damp Wall Street Pre-Bell; Europe Down, Asia Off
31/01MARKT USA/Wall Street dürfte mit leichten Abschlägen starten
31/01Marketmind: 'Soft landing' or 'no landing'?
31/01CAC40 : la prudence domine avant de nombreux résultats
31/01Bolsa de Madrid: Un poco de tensión ante la Fed
31/01Un peu de tension avant la Fed
31/01En Direct des Marchés : Sanofi, Technip Energies, Elis, Seb, EuroA..
31/01CAC 40 : la pause se prolonge malgré de bonnes surprises
31/01Dax vor Fed-Entscheid zur Eröffnung niedriger erwartet
31/01Marketmind: Mind the gap
31/01TAGESVORSCHAU/Dienstag, 31. Januar
31/01WOCHENVORSCHAU: Termine bis 13. Februar 2023
31/01PrescriberPoint, Inc. announced that it has received funding from Eli Lilly and Company..
30/01Wall Street termine en berne au début d'une semaine chargée, donc risquée
30/01Marketmind: Fasten your seatbelts
30/01Recogida de beneficios en Wall Street en una semana decisiva para el mercado
30/01Wall Street démarre en baisse une semaine économique très chargée
30/01South Africa Expects Delivery of Pediatric Pfizer/BioNTech COVID Vaccine Soon
30/01TAGESVORSCHAU/Dienstag, 31. Januar (vorläufige Fassung)
30/01Wdh/Aktien New York Ausblick: Schwach - Warten auf Tech-Zah..
30/01Ribon Therapeutics and Pfizer Have Enter into an Agreement
30/01Moderna Gets FDA Breakthrough Designation for RSV Vaccine Candidate
30/01Paxlovid sales forecasts may change with Pfizer view on China
30/01South Africa Signs Collaboration With Pharmaceutical Association Including GSK, AstraZe..
30/01Ribon Therapeutics, Inc. announced that it has received $25 million in funding from Pfi..
29/01'WamS': Bislang über 250 Corona-Impfschaden-Anträge genehmigt
27/01Health Care Down Ahead of Earnings -- Health Care Roundup
27/01S&P 500 Posts 2.5% Weekly Gain Led by Consumer Discretionary, Technology as Q4 GDP, Som..
27/01WOCHENVORSCHAU: Termine bis 10. Februar 2023
27/01Pfizer, BioNTech Reportedly in Talks with EU Over Reducing COVID-19 Vaccine Orders
27/01Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases - CDC
Volgende evenement op PFIZER, INC.